heart failure: torsemide vs furosemide
A recent open-label, pragmatic randomized trial of patients with heart failure found no difference if using torsemide versus furosemide as the loop diuretic ( see chf torsemide vs furos JAMA Card2023 in dropbox, or https://jamanetwork.com/journals/jama/fullarticle/2800428?guestAccessKey=5afad846-ee09-457e-83c5-1cef2f98e0ad&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamacardiology&utm_content=olf&utm_term=012523 ) Details : -- 2859 participants, all hospitalized with heart failure at 60 hospitals in the United States, were recruited from June 2018 through March 2022 -- they had either newly diagnosed heart failure (30% of them), the rest had chronic heart failure and were hospitalized for heart failure in the past year -- mean age 64, 35% female, 58% white/33% Black/5% Hispanic -- left ventricular ejection fraction>50% in 24% of the patients/ <40% in 70%/41-49% in 6% ...